Literature DB >> 15189915

Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?

Giovanna E Carpagnano1, Peter J Barnes, Jackie Francis, Nicola Wilson, Andrew Bush, Sergei A Kharitonov.   

Abstract

STUDY
OBJECTIVES: The noninvasive assessment and monitoring of airway inflammation could be important in respiratory disease. The pH of exhaled breath condensate (EBC) is a promising marker. Although pH has been measured in the EBC of adults with inflammatory airway diseases, no study has measured this in children.
DESIGN: This study aimed to assess whether there is a change in pH in the EBC of children with cystic fibrosis (CF) and asthma, and to try to determine whether pH could be used as a marker of airway inflammation. Furthermore, the relationships among EBC pH, severity of disease, and oxidative stress were studied. PATIENTS AND METHODS: We studied 20 children with CF (mean [+/- SEM] age, 7 +/- 3 years), 20 children with asthma (mean age, 7 +/- 2 years), and 15 age-matched healthy children (mean age, 7 +/- 2 years). The pH of EBC was measured using a pH meter. MEASUREMENTS AND
RESULTS: Lower pH values were observed in the EBC of children with CF and asthma compared to control subjects (mean pH, 7.23 +/- 0.03 and 7.42 +/- 0.01 vs 7.85 +/- 0.02, respectively). Furthermore, relationships among EBC pH, severity of asthma, and the presence of an infective exacerbation of CF was found. There was a negative correlation between exhaled pH and exhaled leukotriene B(4) concentrations (r = -0.5; p < 0.005).
CONCLUSION: We conclude that the measurement of EBC pH may be useful in the evaluation of airway inflammation in children with asthma and CF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189915     DOI: 10.1378/chest.125.6.2005

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

Review 1.  Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma.

Authors:  Jiangtao Lin; Kaisheng Yin; Nan Su; Mao Huang; Chen Qiu; Chuntao Liu; Shaoxi Cai; Chuangli Hao
Journal:  Ann Transl Med       Date:  2015-11

Review 2.  Chinese expert consensus on clinical use of non-invasive airway inflammation assessment in bronchial asthma.

Authors:  Jiangtao Lin; Kaisheng Yin; Nan Su; Mao Huang; Chen Qiu; Chuntao Liu; Shaoxi Cai; Chuangli Hao
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

Review 3.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

Review 4.  Exhaled breath condensate pH assays.

Authors:  John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2007-11       Impact factor: 3.479

Review 5.  Are exhaled breath condensates useful in monitoring asthma?

Authors:  Fanny W S Ko; T F Leung; David S C Hui
Journal:  Curr Allergy Asthma Rep       Date:  2007-04       Impact factor: 4.806

6.  Exhaled breath condensate pH in patients with cystic fibrosis.

Authors:  Balazs Antus; Imre Barta; Eszter Csiszer; Krisztina Kelemen
Journal:  Inflamm Res       Date:  2012-06-16       Impact factor: 4.575

7.  The effects of volatile salivary acids and bases on exhaled breath condensate pH.

Authors:  Richard M Effros; Richard Casaburi; Jennifer Su; Marshall Dunning; John Torday; Julie Biller; Reza Shaker
Journal:  Am J Respir Crit Care Med       Date:  2005-11-10       Impact factor: 21.405

8.  Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner.

Authors:  Leah C Kottyan; Ann R Collier; Khanh H Cao; Kathryn A Niese; Megan Hedgebeth; Caius G Radu; Owen N Witte; Gurjit K Khurana Hershey; Marc E Rothenberg; Nives Zimmermann
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

9.  Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma.

Authors:  Anne M Fitzpatrick; Janet T Holbrook; Christine Y Wei; Meredith S Brown; Robert A Wise; W Gerald Teague
Journal:  J Allergy Clin Immunol Pract       Date:  2014-05-21

10.  How strong is the association between IPF and lung cancer? An answer from airway's DNA.

Authors:  G E Carpagnano; D Lacedonia; P Soccio; I Caccavo; G Patricelli; M P Foschino Barbaro
Journal:  Med Oncol       Date:  2016-09-29       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.